List of works - Andrea Mancuso

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature

scientific article published on February 2013

Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis

scientific article published on 07 November 2017

An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment.

scientific article

Anticoagulation for Portal Vein Thrombosis in Cirrhosis

scientific article published on 01 June 2019

Anticoagulation for portal vein thrombosis in cirrhosis: Which is the rational?

scientific article published on 04 June 2019

Budd-Chiari syndrome hemodynamic: Clinical setting more complicated than computational model

scientific article published on 16 July 2019

Budd-Chiari syndrome in the West and the East: Same syndrome, different diseases

scientific article published on 24 May 2019

Budd-Chiari syndrome management: Lights and shadows ⬇️

scientific article published on October 27, 2011

Budd-chiari syndrome management: Timing of treatment is an open issue

scientific article published on 16 January 2014

Cirrhosis development probably arises from chronic micro-vascular ischemia

scientific article published on 8 December 2013

Classification of Portal Vein Thrombosis in Cirrhosis

scientific article published on 06 March 2017

Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population

scientific article published on 24 February 2019

Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta‐analysis

scientific article published in 2022

Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients

Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation

scientific article published on 08 June 2011

Hepatocellular carcinoma in thalassaemia - emerging issues and challenges for liver transplant

scientific article published on 01 December 2014

Hepatocellular carcinoma in thalassemia: A critical review ⬇️

scientific article published on May 27, 2010

In favour of early intervention for Budd-Chiari syndrome: another brick in the wall

scientific article published on 01 July 2016

Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients.

scientific article

Letter: Target of TIPSS for Budd-Chiari syndrome should be avoiding liver transplant

scientific article published on 01 June 2014

Letter: management of portal vein thromboses in cirrhosis

scientific article published on 01 April 2015

Letter: why treatments of hepatitis C virus are less effective in cirrhosis.

scientific article published in April 2015

Limits of Evidence Based Medicine for rare diseases: The case of Budd-Chiari syndrome

article

Management of Budd-Chiari syndrome in children: same debated issues as in adults

scientific article published on 01 January 2015

Management of Suprahepatic Inferior Vena Cava Obstruction

scientific article published on 08 August 2016

Management of antiplatelet treatment in patients undergoing endoscopic procedures.

scientific article published in April 2010

Management of hepatocellular carcinoma in thalassemia and importance of the human factor

scientific article published on 13 January 2017

Management of hepatocellular carcinoma recurrence after liver transplant is far from perfect

scientific article published on 25 April 2017

Management of hepatocellular carcinoma: Enlightening the gray zones.

scientific article published on June 2013

Management of portal vein thrombosis in cirrhosis: More shadows than lights.

scientific article published on 26 March 2016

Management of portal vein thrombosis in cirrhosis: an update

scientific article published on 13 April 2016

Music for colonoscopy: A single-blind randomized controlled trial.

scientific article

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis

scientific article published on 01 July 2020

Outcome of Budd-Chiari syndrome in Behçet׳s syndrome

scientific article published on 08 April 2015

Portal Hypertension

scientific article published on 04 November 2018

Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?

scientific article published on 17 January 2018

Prognostic Assessment and Management of Liver Cirrhosis

scientific article published on August 2017

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China

scientific article

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

scientific article

Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?

scientific article published on 01 May 2014

Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment.

scientific article

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis

scientific article

Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients.

scientific article published in August 2004

TIPS for Budd-Chiari syndrome: time to anticipate treatment

scientific article published on 10 April 2014

The ischemic liver cirrhosis theory and its clinical implications.

scientific article

Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?

scientific article published on 22 August 2014

Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant

scientific article published on 01 April 2015

Time to resize the role of liver transplant for Budd-Chiari syndrome.

scientific article published on 27 March 2015

Transient portal vein thrombosis in liver cirrhosis.

scientific article published on 5 June 2018

Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis: Individualised or Non-reproducible Strategy?

scientific article published on 03 May 2018

Treatment of portal vein thrombosis in cirrhosis: is it really needed?

scientific article published on 01 August 2018

Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding?

scientific article published on 24 November 2017

Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis.

scientific article

List of works by Andrea Mancuso

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature

Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis

An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment.

Anticoagulation for Portal Vein Thrombosis in Cirrhosis

Anticoagulation for portal vein thrombosis in cirrhosis: Which is the rational?

Budd-Chiari syndrome hemodynamic: Clinical setting more complicated than computational model

Budd-Chiari syndrome in the West and the East: Same syndrome, different diseases

Budd-Chiari syndrome management: Lights and shadows ⬇️

Budd-chiari syndrome management: Timing of treatment is an open issue

Cirrhosis development probably arises from chronic micro-vascular ischemia

Classification of Portal Vein Thrombosis in Cirrhosis

Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population

Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta‐analysis

Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients

Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation

Hepatocellular carcinoma in thalassaemia - emerging issues and challenges for liver transplant

Hepatocellular carcinoma in thalassemia: A critical review ⬇️

In favour of early intervention for Budd-Chiari syndrome: another brick in the wall

Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients.

Letter: Target of TIPSS for Budd-Chiari syndrome should be avoiding liver transplant

Letter: management of portal vein thromboses in cirrhosis

Letter: why treatments of hepatitis C virus are less effective in cirrhosis.

Limits of Evidence Based Medicine for rare diseases: The case of Budd-Chiari syndrome

Management of Budd-Chiari syndrome in children: same debated issues as in adults

Management of Suprahepatic Inferior Vena Cava Obstruction

Management of antiplatelet treatment in patients undergoing endoscopic procedures.

Management of hepatocellular carcinoma in thalassemia and importance of the human factor

Management of hepatocellular carcinoma recurrence after liver transplant is far from perfect

Management of hepatocellular carcinoma: Enlightening the gray zones.

Management of portal vein thrombosis in cirrhosis: More shadows than lights.

Management of portal vein thrombosis in cirrhosis: an update

Music for colonoscopy: A single-blind randomized controlled trial.

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis

Outcome of Budd-Chiari syndrome in Behçet׳s syndrome

Portal Hypertension

Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?

Prognostic Assessment and Management of Liver Cirrhosis

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?

Splanchnic Vein Thrombosis: Etiology, Diagnosis, and Treatment.

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis

Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients.

TIPS for Budd-Chiari syndrome: time to anticipate treatment

The ischemic liver cirrhosis theory and its clinical implications.

Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?

Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant

Time to resize the role of liver transplant for Budd-Chiari syndrome.

Transient portal vein thrombosis in liver cirrhosis.

Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis: Individualised or Non-reproducible Strategy?

Treatment of portal vein thrombosis in cirrhosis: is it really needed?

Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding?

Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis.